PARAMUS, N.J.—WG Critical Care LLC, (WGCC) a leading pharmaceutical company invested in delivering products that enhance patient safety and workflow efficiency for hospital pharmacies, has introduced a 2-g vial of meropenem for injection, USP.
This is the first and only FDA-approved 2-g meropenem vial to be introduced, the company announced in a press release.
The product is compatible with IV admixing systems, which enables storing in automated dispensing cabinets. Moreover, it carries a